Our earliest capture with readable facts. This is our first observation, not when the company introduced these things. These website claims are not independently verified.
How it described itself
One Sample, Many Answers.
A multi omics technology company developing a next generation quantitative and digital platform for nucleic acid and protein assays.
All facts above belong to this capture. Unlisted fields mean we have no readable observation, not that they were absent.
How it describes itself
Similar headlines are grouped together. The quote shown is from the last capture in each group, not necessarily the exact wording throughout that period.
December 2025 – November 2026 · 4 captures · latest observed messagingCodetta Bio Concerto™ System
Unleash the future of multiplex biomarker measurements with the Codetta Bio Platform. Experience the precision of Digital PCR, and the Dynamic Range of qPCR applied to measurement of blood-based prote